Gibbs & Bruns achieved a favorable settlement on behalf of DaVita, Inc., one of the world’s largest providers of dialysis services. DaVita had been sued in a substantial and complicated qui tam lawsuit in the Eastern District of Texas, in which a private individual pursued claims on behalf of the United States government. The claims involved allegedly improper over-administration and billing for a commonly used anti-anemia drug over a 15-plus year time period. Under the settlement, in which DaVita denies all wrongdoing, DaVita obtained a complete dismissal with prejudice, will not be subject to a corporate integrity agreement or other oversight program, and will continue full participation in government healthcare programs. Our firm was selected for this high-profile case because of our successful record of trying major litigation matters of this complexity.
